Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CGC

Canopy Growth Corp Restates Financials for Accounting Error

Canopy Growth said it expects to report fiscal fourth-quarter and full-year 2026 results on June 15, 2026, while also restating results for fiscal 2025 and fiscal 2024.

The company said it identified a technical accounting error tied to share-settled warrants issued in fiscal 2024. Those warrants, denominated in U.S. dollars, should have been treated as liabilities rather than equity because Canopy’s functional currency is the Canadian dollar. The correction will require the company to mark those instruments to fair value at each reporting date, with changes flowing through the income statement.

Canopy said the restatement is expected to be limited to reclassifications between equity and liabilities and related fair-value adjustments, all non-cash items. It said the correction is not expected to change revenue, gross margin, operating income or loss, cash from operations, adjusted EBITDA, total assets, cash balances, liquidity, debt covenant compliance or borrowing capacity.

The company also said it has applied for a management cease trade order covering certain directors and officers until the refiling is complete. It plans to provide bi-weekly status updates until the restatement process is finished and the order is revoked.

Canopy’s June 15 release will include restated financial results for fiscal 2025 and fiscal 2024 alongside the results for the year ended March 31, 2026. Following these announcements, the company's shares moved -2.8%, and are now trading at a price of $1.04. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS